Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο: https://hdl.handle.net/10442/17426
Export to:   BibTeX  | EndNote  | RIS
Εξειδίκευση τύπου : Άρθρο σε επιστημονικό περιοδικό
Τίτλος: 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound
Δημιουργός/Συγγραφέας: Filippopoulou K.
Papaevgeniou N.
Lefaki M.
Paraskevopoulou A.
Biedermann D.
Křen V.
[EL] Χονδρογιάννη, Νίκη[EN] Chondrogianni, Nikisemantics logo
Εκδότης: Elsevier Inc.
Ημερομηνία: 2017
Γλώσσα: Αγγλικά
ISSN: 0891-5849
DOI: 10.1016/j.freeradbiomed.2016.12.042
Άλλο: PubMed ID: 28039083
Περίληψη: Aging is an unavoidable process characterized by gradual failure of homeostasis that constitutes a critical risk factor for several age-related disorders. It has been unveiled that manipulation of various key pathways may decelerate the aging progression and the triggering of age-related diseases. As a consequence, the identification of compounds, preferably natural-occurring, administered through diet, with lifespan-extending, anti-aggregation and anti-oxidation properties that in parallel exhibit negligible side-effects is the main goal in the battle against aging. Here we analyze the role of 2,3-dehydrosilybin A/B (DHS A/B), a minor component of silymarin used in a plethora of dietary supplements. This flavonolignan is well-known for its anti-oxidative and neuroprotective properties, among others. We demonstrate that DHS A/B confers oxidative stress resistance not only in human primary cells but also in the context of a multi-cellular aging model, namely Caenorhabditis elegans (C. elegans) where it also promotes lifespan extension. We reveal that these DHS A/B outcomes are FGT-1 and DAF-16 dependent. We additionally demonstrate the anti-aggregation properties of DHS A/B in human cells of nervous origin but also in nematode models of Alzheimer's disease (AD), eventually leading to decelerated progression of AD phenotype. Our results identify DHS A/B as the active component of silymarin extract and propose DHS A/B as a candidate anti-aging and anti-aggregation compound.
Τίτλος πηγής δημοσίευσης: Free Radical Biology and Medicine
Τόμος/Κεφάλαιο: 103
Σελίδες: 256-267
Θεματική Κατηγορία: [EL] Βιολογία (Γενικά)[EN] Biology (General)semantics logo
Λέξεις-Κλειδιά: 2,3-dehydrosilybin A/B
Anti-aggregation
Anti-aging
Anti-oxidation
DAF-16
FGT-1
Αξιολόγηση από ομότιμους (peer reviewed): Ναι
Κάτοχος πνευματικών δικαιωμάτων: © 2017 Elsevier Inc.
Σημειώσεις: National Center for Research Resources, NCRR: 3.7.12 MIS380228; European Commission, EC; European Cooperation in Science and Technology, COST; Ministerstvo Školství, Mládeže a Tělovýchovy, MŠMT: LD15081; European Social Fund, ESF
Εμφανίζεται στις συλλογές:Ινστιτούτο Χημικής Βιολογίας - Επιστημονικό έργο

Αρχεία σε αυτό το τεκμήριο:
Το πλήρες κείμενο αυτού του τεκμηρίου δεν διατίθεται προς το παρόν από τον ΗΛΙΟ.